Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

Theralase Technologies Inc.

Aug 2007
In Toronto, Theralase Technologies Inc., University Health Network and the Ontario Centres of Excellence have expanded their joint research and development effort. The initiative will focus on Theralase’s photodynamic compounds and the TLC-3000 super-pulsed biofeedback laser used to activate them. Although the research will seek to improve the effectiveness of the compound and laser for targeted destruction of cancers, bacteria, viruses and fat cells, the products also are used for pain management and clinical therapy as well as wound care and healing.

BiophotonicsNews & Featuresphotodynamic compoundsTheralase Technologies Inc.lasers

Terms & Conditions Privacy Policy About Us Contact Us
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2019 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA,

Photonics Media, Laurin Publishing
x Subscribe to BioPhotonics magazine - FREE!
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.